Cargando…
Recent successes in therapeutics for Ebola virus disease: no time for complacency
The PALM trial in the Democratic Republic of the Congo identified a statistically significant survival benefit for two monoclonal antibody-based therapeutics in the treatment of acute Ebola virus disease; however, substantial gaps remain in improving the outcomes of acute Ebola virus disease and for...
Autores principales: | Iversen, Patrick L, Kane, Christopher D, Zeng, Xiankun, Panchal, Rekha G, Warren, Travis K, Radoshitzky, Sheli R, Kuhn, Jens H, Mudhasani, Rajini R, Cooper, Christopher L, Shurtleff, Amy C, Nasar, Farooq, Sunay, Melek ME, Duplantier, Allen J, Eaton, Brett P, Zumbrun, Elizabeth E, Bixler, Sandra L, Martin, Shannon, Meinig, J Matthew, Chiang, Chih-Yuan, Sanchez-Lockhart, Mariano, Palacios, Gustavo F, Kugelman, Jeffrey R, Martins, Karen A, Pitt, Margaret L, Crozier, Ian, Saunders, David L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302789/ https://www.ncbi.nlm.nih.gov/pubmed/32563280 http://dx.doi.org/10.1016/S1473-3099(20)30282-6 |
Ejemplares similares
-
Combating biothreat pathogens: ongoing efforts for countermeasure development and unique challenges
por: Duplantier, Allen J., et al.
Publicado: (2020) -
Complacency or Conquest?
por: Keers, R. Y.
Publicado: (1953) -
Self Complacency
Publicado: (1859) -
High Content Image Based Analysis Identifies Cell Cycle Inhibitors as Regulators of Ebola Virus Infection
por: Kota, Krishna P., et al.
Publicado: (2012) -
COVID-19 in Africa: no room for complacency
por: The Lancet
Publicado: (2020)